Treatment of thoracic esophageal carcinoma invading adjacent structures

Cancer Science

Volumn 98, Issue 7, 2007, Pages 937-942

  Seto, Yasuyuki ^a   Chin, Keisho ^a   Gomi, Kotaro ^a   Kozuka, Takuyo ^a   Fukuda, Takashi ^a   Yamada, Kazuhiko ^a   Matsubara, Toshiki ^a   Tokunaga, Masanori ^a   Kato, Yo ^a   Yafune, Akifumi ^b   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b Clinic Sendagaya   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; ESOPHAGUS CARCINOMA; FIBROSIS; HUMAN; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; SURVIVAL RATE; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249907876     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00479.x     Document Type: Review

References (79)

1. Tachibana M, Dhar DK, Kinugasa S et al. Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus. Dysphagia 2002; 17: 255-61.
2. Matsubara T, Ueda M, Kokudo N, Takahashi T, Muto T, Yanagisawa A. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 2001; 25: 279-84.
3. Noguchi T, Moriyama H, Wada S et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 2003; 16: 94-8.
4. Ikeda K, Ishida K, Sato N et al. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus 2001; 14: 197-201.
5. Fujita H, Sueyoshi S, Tanaka T et al. Prospective non-randomized trial comparing esophagectomy followed by chemoradiotherapy versus chemoradiotherapy followed by esophagectomy for T4 esophageal cancers. J Surg Oncol 2005; 90: 209-19.
6. Fujita H, Sueyoshi S, Tanaka T et al. Esophagectomy: Is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 2005; 29: 25-31.
7. Itoh Y, Fuwa N, Matsumoto A, Asano A, Morita K. Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer -retrospective analysis. Radiat Med 2001; 19: 231-5.
8. Tabira Y, Yasunaga M, Nakano K et al. All pathological T4 esophageal carcinomas should be categorized as stage IV. Hepatogastroenterology 2002; 49: 694-8.
9. Fockens P, Kisman K, Merkus MP, van Lanschot JJB, Obertop H, Tytgat GN. The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg 1998; 186: 17-23.
10. Ancona E, Ruol A, Chiarion-Sileni V et al. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus. Ann Surg 1997; 226: 714-24.
11. Malaisrie SC, Untch B, Aranha GV, Mohideen N, Hantel A, Pickleman J. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer. Arch Surg 2004; 139: 532-9.
12. Yano M, Tsujinaka T, Shiozaki H et al. Concurrent chemotherapy (5-Fluorouracil and Cisplatin) and radiation therapy followed by surgery T4 squamous cell carcinoma of the esophagus. J Surg Oncol 1999; 70: 25-32.
13. Fujiwara Y, Kamikonya N, Inoue T et al. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: A preliminary report. Oncol Rep 2005; 14: 1177-82.
14. Van Raemdonck D, Van Cutsem E, Menten J et al. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 1997; 11: 828-37.
15. Murakami M, Kuroda Y, Matsusue S et al. Treatment results of esophageal carcinoma of clinical T3, T4M0: Historical comparison between neoadjuvant chemoradiotherapy followed by surgery or definitive radiotherapy and conventional surgery. Oncol Rep 2000; 7: 571-8.
16. Kaneko K, Ito H, Konishi K et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the esophagus. Br J Cancer 2003; 88: 18-24.
17. Ishikura S, Nihei K, Ohtsu A et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003; 21: 2697-702.
18. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/ or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
19. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: A Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 2004; 34: 615-9.
20. Crosby TDL, Brewster AE, Perschky L, Kehagioglou P, Court J, Maughan TS. Definitive chemoradiation in patients with inoperable oesophagus carcinoma. Br J Cancer 2004; 90: 70-5.
21. Chak A, Canto M, Gerdes H et al. Prognosis of esophageal cancers preoperatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): A multicenter retrospective cohort study. Gastrointest Endosc 1995; 42: 501-6.
22. Berger AC, Farma J, Scott WJ et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-7.
23. Gill PG, Denham JW, Jamieson GG, Devitt PG, Yeoh E, Olweny C. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 1992; 10: 1037-43.
24. de Pree C, Aapro MS, Spiliopoulos A et al. Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol 1995; 6: 551-7.
25. Algan O, Coia LR, Keller SM et al. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: Results of sequential nonrandomized phase II studies. Int J Radiation Oncol Biol Phys 1995; 32: 753-61.
26. Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiation Oncol Biol Phys 1999; 45: 265-70.
27. Coia LR, Minsky BD, Berkey BA et al. Outcome of patients receiving radiation for cancer of the esophagus: Results of the patterns of care study. J Clin Oncol 2000; 18: 455-62.
28. Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiation Oncol Biol Phys 2004; 60: 1484-93.
29. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-17.
30. Zhang Z, Liao Z, Jin J et al. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 656-64.
31. Meunier B, Raoul JL, Le Prise E, Lakehal M, Launois B. Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus. Dig Surg 1998; 15: 224-6.
32. Swisher SG, Wynn P, Putnam JB et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002; 123: 175-83.
33. Nakamura T, Hayashi K, Ota M et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004; 188: 261-6.
34. Tomimaru Y, Yano M, Takachi K et al. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 2006; 93: 422-8.
35. Seto Y, Yamada KT, Fukuda Hosoi N et al. Esophageal bypass using a gastric tube and a cardiostomy for malignant esophago-respiratory fistula. Am J Surg 2007 (in press).
36. Parker EF, Gregorie HB. Combined radiation and surgical treatment of carcinoma of the esophagus. Ann Surg 1965; 161: 710-18.
37. Nakayama K, Orihata H, Yamaguchi K. Surgical treatment combined with preoperative concentrated irradiation for esophageal cancer. Cancer 1967; 20: 778-88.
38. Akakura I, Nakamura Y, Kakegawa T, Nakayama R, Watanabe H, Yamashita H. Surgery of carcinoma of the esophagus with preoperative radiation. Chest 1970; 57: 47-57.
39. Parker EF, Gregorie HB, Arrants JE, Ravenel JM. Carcinoma of the esophagus. Ann Surg 1970; 171: 746-50.
40. Marks RD, Sgruggs HJ, Wallace KM. Preoperative radiation therapy for carcinoma of the esophagus. Cancer 1976; 38: 84-9.
41. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gyne Obst 1981; 153: 690-3.
42. Gignoux M, Roussel A, Paillot B et al. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the EORTC. World J Surg 1987; 11: 426-32.
43. Iizuka T, Ide H, Kakegawa T et al. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 1988; 93: 1054-8.
44. Arnott SJ, Duncan W, Kerr GR et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial. Radio Oncol 1992; 24: 108-13.
45. Arnott SJ, Duncan W, Gignoux M et al. Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data. Int J Rad Oncol Biol Phys 1998; 41: 579-83.
46. Steiger Z, Franklin R, Wilson RF et al. Complete eradication of squamous cell carcinoma of the esophagus with combined chemotherapy and radiotherapy. Am Surg 1981; 47: 95-8.
47. Leichman L, Steiger Z, Seydel H, Vaitkevicius VK. Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: The Wayne state University, Southwest Oncology Group and Radiation Therapy Oncology Group experience. Semin Oncol 1984; 11: 178-85.
48. Poplin E, Fleming T, Leichman L et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987; 5: 622-8.
49. Richmond J, Seydel HG, Bae Y, Lewis J, Burdakin J, Jacobsen G. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987; 13: 1617-20.
50. Seydel HG, Leichman L, Byhardt R et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: A RTOG study. Int J Radiation Oncol Biol Phys 1988; 14: 33-5.
51. Lackey VL, Reagan MT, Smith RA, Anderson WJ. Neoadjuvant therapy of squamous cell carcinoma of the esophagus: Role of resection and benefit in partial responders. Ann Thorac Surg 1989; 48: 218-21.
52. Naunheim KS, Petruska PJ, Roy TS et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 1992; 103: 887-95.
53. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
54. Tamin WZ, Davidson RS, Quinlan RM, Oshea MA, Orr RK, Swanson RS. Neoadjuvant chemoradiotherapy for esophageal cancer. Arch Surg 1998; 133: 722-6.
55. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Resectable esophageal carcinoma: Local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999; 213: 67-72.
56. Hennequin C, Gayet B, Sauvanet A et al. Impact on survival surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001; 49: 657-64.
57. Posner MC, Gooding WE, Lew JI, Rosenstein MM, Lembersky BC. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Surgery 2001; 130: 620-8.
58. Wilson KS, Wilson AG, Dewar GJ. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998. Can J Gastroenterol 1993; 16: 361-8.
59. Lee JL, Park SI, Kim SB et al. A single institutional phase III trial of preoperative chemotherapy with hyperfraction radiotherapy plus surgery versus surgery alone for respectable esophageal squamous cell carcinoma. Ann Oncol 2004; 15: 947-54.
60. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P. Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group. Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the esophagus: A randomized controlled phase III trial. Lancet Oncol 2005; 6: 659-68.
61. Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG. Neoadjuvant chemoradiotherapy for esophageal carcinoma. Dis Esophagus 2005; 18: 104-8.
62. Yamashita H, Nakagawa K, Tago M et al. Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma. Radiat Med 2006; 24: 65-71.
63. Le Prise EA, Meunier BC, Etienne PL et al. Sequential chemotherapy and radiotherapy for patients with squamous cell carcinoma of the esophagus. Cancer 1995; 75: 430-4.
64. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
65. Al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997; 15: 277-84.
66. Cooper JS, Guo MD, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 281: 1623-7.
67. Minsky BD, Pajak TF, Ginsberg RJ et al. INT o123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
68. Urschel JD, Ashiku S, Thurer R, Sellke FW. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer -a review. Dis Esophagus 2003; 16: 60-5.
69. Urschel JD, Sellke FW. Complications of salvage esophagectomy. Med Sci Monit 2003; 9: 173-80.
70. Sauter ER, Coia LR, Keller SM. Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction. Ann Surg Oncol 1994; 1: 5-10.
71. Keller SM, Ryan LM, Coia LR et al. High-dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and esophagogastric junction. Cancer 1998; 83: 1908-16.
72. Lee HK, Vaporciyan AA, Cox JD et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-Volume histogram parameters. Int J Radiat Oncol Biol Phys 2003; 57: 1317-22.
73. Abou-Jawde RM, Mekhail T, Adelstein DJ et al. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 2005; 128: 250-5.
74. Wang SL, Liao Z, Vaporciyan AA et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2006; 64: 692-9.
75. Perez CA, Pajak TF, Rubin P et al. Long-term observations of the pattern of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987; 59: 1874-81.
76. Di Fiore F, Lecleire S, Galais MP et al. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroenterol Clin Biol 2006; 30: 845-51.
77. Jin J, Liao Z, Zhang Z et al. Induction chemotherapy improved outcomes of patients with respectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004; 60: 427-36.
78. Henry LR, Goldberg M, Scott W et al. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: A phase II report. Ann Surg Oncol 2006; 13: 214-20.
79. van Meerten E, Muller K, Tilanus HW et al. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with esophageal cancer: A phase II study. Br J Cancer 2006; 94: 1389-94.